ARTICLE | Company News
Cellex other research news
June 12, 1995 7:00 AM UTC
CLXX received an $80,000 Phase I SBIR from the National Institute of Diabetes and Digestive and Kidney Diseases to evaluate the Minneapolis company's Oxycell cell culture technology to grow human bone...